RASOLA, Andrea
RASOLA, Andrea
Dip. SCIENZE ONCOLOGICHE - Candiolo (attivo dal 01/01/2002 al 30/04/2013)
A positive feedback loop between hepatocyte growth factor receptor and beta-catenin sustains colorectal cancer cell invasive growth
2007-01-01 RASOLA A; FASSETTA M; DE BACCO F; D'ALESSANDRO L; GRAMAGLIA D; DI RENZO MF; COMOGLIO PM
Genes regulated by hepatocyte growth factor as targets to sensitize ovarian cancer cells to cisplatin
2006-01-01 OLIVERO M; RUGGIERO T; SAVIOZZI S; RASOLA A; COLTELLA N; CRISPI S; DI CUNTO F; CALOGERO R; DI RENZO MF
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis
2016-01-01 Kowalik, Marta Anna; Guzzo, Giulia; Morandi, Andrea; Perra, Andrea; Menegon, Silvia; Masgras, Ionica; Trevisan, Elena; Angioni, Maria Maddalena; Fornari, Francesca; Quagliata, Luca; Ledda-Columbano, Giovanna Maria; Gramantieri, Laura; Terracciano, Luigi; Giordano, Silvia; Chiarugi, Paola; Rasola, Andrea; Columbano, Amedeo
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming
2020-01-01 Kowalik M.A.; Puliga E.; Cabras L.; Sulas P.; Petrelli A.; Perra A.; Ledda-Columbano G.M.; Morandi A.; Merlin S.; Orru C.; Sanchez-Martin C.; Fornari F.; Gramantieri L.; Parri M.; Rasola A.; Bellomo S.E.; Sebastian C.; Follenzi A.; Giordano S.; Columbano A.
Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD+ and SIRT3
2022-01-01 Masgras I.; Cannino G.; Ciscato F.; Sanchez-Martin C.; Darvishi F.B.; Scantamburlo F.; Pizzi M.; Menga A.; Fregona D.; Castegna A.; Rasola A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A positive feedback loop between hepatocyte growth factor receptor and beta-catenin sustains colorectal cancer cell invasive growth | 2007 | RASOLA A; FASSETTA M; DE BACCO F; D'ALESSANDRO L; GRAMAGLIA D; DI RENZO MF; COMOGLIO PM | |
| Genes regulated by hepatocyte growth factor as targets to sensitize ovarian cancer cells to cisplatin | 2006 | OLIVERO M; RUGGIERO T; SAVIOZZI S; RASOLA A; COLTELLA N; CRISPI S; DI CUNTO F; CALOGERO R; DI RENZO MF | |
| Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis | 2016 | Kowalik, Marta Anna; Guzzo, Giulia; Morandi, Andrea; Perra, Andrea; Menegon, Silvia; Masgras, Ionica; Trevisan, Elena; Angioni, Maria Maddalena; Fornari, Francesca; Quagliata, Luca; Ledda-Columbano, Giovanna Maria; Gramantieri, Laura; Terracciano, Luigi; Giordano, Silvia; Chiarugi, Paola; Rasola, Andrea; Columbano, Amedeo | |
| Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming | 2020 | Kowalik M.A.; Puliga E.; Cabras L.; Sulas P.; Petrelli A.; Perra A.; Ledda-Columbano G.M.; Morandi A.; Merlin S.; Orru C.; Sanchez-Martin C.; Fornari F.; Gramantieri L.; Parri M.; Rasola A.; Bellomo S.E.; Sebastian C.; Follenzi A.; Giordano S.; Columbano A. | |
| Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD+ and SIRT3 | 2022 | Masgras I.; Cannino G.; Ciscato F.; Sanchez-Martin C.; Darvishi F.B.; Scantamburlo F.; Pizzi M.; Menga A.; Fregona D.; Castegna A.; Rasola A. |